Thoracic Malignancies: A Review of the Latest Evidence
Date: Saturday, November 1, 2025
7:30 am Check-in & Breakfast
8:00 am – 3:00 pm CME Program
Location:
Philadelphia Marriott Old City
One Dock Street, Philadelphia, PA 19106
The rapid evolution of information surrounding the management of thoracic malignancies presents ongoing challenges for physicians tasked with selecting the most appropriate treatment strategies. To address this, Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education are offering a comprehensive course focused on the latest advances in the detection, imaging, diagnosis, staging, treatment, and research of non-small cell lung cancer (NSCLC).
This full-day CME event features experts from Fox Chase/Temple Health, Massachusetts General Hospital/Harvard Medical School, Penn Medicine, Jefferson Health, Cooper University Health Care, Montefiore Einstein Comprehensive Cancer Center, Alliance Cancer Specialists and Virginia Cancer Specialists. The course is designed to provide practical, up-to-date insights for anyone involved in the care of lung cancer patients or seeking a current overview of the field.
Educational Objectives
• Identify MET IHC-positive tumors and select appropriate treatment strategies.
• Select patients with early-stage lung cancer who are appropriate candidates for neoadjuvant therapy.
• Determine the optimal frontline treatment for patients with advanced EGFR-mutated NSCLC.
Keynote Speaker
Zosia Piotrowska, MD, MHS
Associate Professor of Medicine, Harvard Medical School
Associate Physician, Medicine-Hematology and Medical Oncology,
Massachusetts General Hospital
Program Director
Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Professor, Department of Hematology/Oncology
Co-Director, Immune Monitoring Facility
Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Planning Advisor
Michael Seidman, MD
Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
Intended Audience
This course is appropriate for primary care and family medicine physicians; medical, surgical, and radiation oncologists; thoracic and general surgeons; pulmonologists; pathologists; radiologists; fellows/residents/students; nurses; physician assistants; advanced practice providers; and researchers involved in the management of patients with lung cancer and thoracic malignancies.
Accreditation Statement
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Designation Statement
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 6 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.
CME AGENDA
Check-In, Breakfast & Exhibits Open (7:30 am–8 am)
Welcome & Opening Remarks (8 am–8:10 am)
- Hossein Borghaei, DO, MS, Fox Chase Cancer Center
Session 1: EGFR (8:10 am–9:10 am)
- KEYNOTE SPEAKER: Front Line Metastatic
Zosia Piotrowska, MD, MHS, Massachusetts General Hospital - Second Line and Beyond Metastatic
Nick Bodor, MD, PhD, MPH, Fox Chase Cancer Center - Adjuvant and Neoadjuvant
Sukhmani Padda, MD, Fox Chase Cancer Center - Management of Toxicities
Zosia Piotrowska, MD, MHS, Massachusetts General Hospital - Panel Discussion and Case Studeis
Session 2: HER2 (9:10 am–9:50 am)
- Brain Mets
Stephanie E. Weiss, MD, FASTRO, Fox Chase Cancer Center - ADC
Parth Desai, MBBS, MD, Fox Chase Cancer Center - TKIs
Lova Sun, MD, MSCE, Penn Medicine’s Abramson Cancer Center - Panel Discussion and Case Studies
Break (9:50 am–10:05 am)
Session 3: Locally Advanced (10:05 am–10:55 am)
- Chemo-RT-IO Studies (No Driver)
Martin J. Edelman, MD, FACP, Fox Chase Cancer Center - New Paradigm: How to Move Forward
Sameera Kumar, MD, Fox Chase Cancer Center - Locally Advanced Disease (Driver Mutation Positive Studies)
Deric Savior, MD, Alliance Cancer Specialists - Panel Discussion and Case Studies
Moderator: John C. Ruckdeschal, MD, FACP, FCCP, Fox Chase Cancer Center
Session 4: Early Stage Disease (10:55 am–11:50 am)
- Adjuvant and Neoadjuvant: Updated Data
Corey Langer, MD, Penn Medicine’s Abramson Cancer Center - Adjuvant and Neoadjuvant in Driver Positive Disease
Nick Bodor, MD, PhD, MPH, Fox Chase Cancer Center - Surgical Perspectives
Stacey Su, MD, FACS, Fox Chase Cancer Center - Panel Discussion and Case Studeis
Lunch / Exhibitors (11:50 am–12:50 pm)
Session 5: Metastatic Disease (12:50 pm–2:00 pm)
- Front Line Studies Update
Balazs Halmos, MD, MS, Montefiore Einstein Comprehensive Cancer Center - Post-IO Studies
Hossein Borghaei, DO, MS, Fox Chase Cancer Center - ADCs and Bispecific Antibodies
Neel Belani, MD, Virginia Cancer Specialists - Management of Toxicities
Carolyn Zawislak, PA-C, Fox Chase Cancer Center - Consolidative Radiation Therapy
Sameera Kumar, MD, Fox Chase Cancer Center - Oligo Met, Oligo Progressive, Oligo Whatever
Randi Cohen, MD, MS, Fox Chase Cancer Center - Panel Discussion and Case Studies
Session 6: Small Cell (2:00 pm–2:40 pm)
- Front Line ES-SCLC
Veli Bakalov, MD, Cooper University Health Care - Second Line ES-SCLC
Parth Desai, MBBS, MD, Fox Chase Cancer Center - LS-SCLC
Martin J. Edelman, MD, FACP, Fox Chase Cancer Center - Panel Discussion and Case Studies
Session 7: Tumor Board (2:40 pm–3:20 pm)
- John C. Ruckdeschal, MD, Fox Chase Cancer Center
Jason A. Damsker, MD, FACP, Fox Chase Cancer Center
Leah Holben, MD, Fox Chase Cancer Center
Michael Seidman, MD, Fox Chase Cancer Center
Stacey Su, MD, FACS, Fox Chase Cancer Center
Ahmad Danish, MD, Fox Chase Cancer Center
Closing Remarks (3:20 pm–3:30 pm)
Inquiries
Lucía Tono, PhD, MEd
Lucia.Tono-Ramirez@tuhs.temple.edu